Skip to content
10-Q

Quarterly Report

Fortress Biotech, Inc. FBIO FBIOP

0001104659-26-061233

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 38.41M sh
Shares Diluted Q1 2026 · Mar 31, 2025 26.45M sh
Dividends Paid Q1 2026 · Mar 31, 2026 $0
Dividends Paid Q1 2026 · Mar 31, 2025 $166K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $203.85M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$19.56M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $255.84M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $79.38M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $91.34M
Stockholders Equity Q1 2026 · Mar 31, 2026 $162.21M
Stockholders Equity Q1 2026 · Dec 31, 2025 $49.87M
Current Liabilities Q1 2026 · Mar 31, 2026 $103.39M
Current Liabilities Q1 2026 · Dec 31, 2025 $49.74M
Total Liabilities Q1 2026 · Mar 31, 2026 $154.5M
Total Liabilities Q1 2026 · Dec 31, 2025 $123.37M
Current Assets Q1 2026 · Mar 31, 2026 $295.48M
Current Assets Q1 2026 · Dec 31, 2025 $123.84M
Total Assets Q1 2026 · Mar 31, 2026 $356.87M
Total Assets Q1 2026 · Dec 31, 2025 $185.55M
Total Assets Q1 2026 · Mar 31, 2025 $178.07M
Eps Diluted Q1 2026 · Mar 31, 2026 $2.82
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.48
Eps Basic Q1 2026 · Mar 31, 2026 $3.44
Eps Basic Q1 2026 · Mar 31, 2025 −$0.48
Sga Expense Q1 2026 · Mar 31, 2026 $15.89M
Sga Expense Q1 2026 · Mar 31, 2025 $25.66M
Net Income Q1 2026 · Mar 31, 2026 $110.37M
Net Income Q1 2026 · Mar 31, 2025 −$10.58M
Operating Income Q1 2026 · Mar 31, 2026 −$7.74M
Operating Income Q1 2026 · Mar 31, 2025 −$22.32M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $6.22M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $4.79M
Revenue Q1 2026 · Mar 31, 2026 $16.04M
Revenue Q1 2026 · Mar 31, 2025 $13.14M